Correlation Between Pharvaris and Easton Pharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Easton Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Easton Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Easton Pharmaceutica, you can compare the effects of market volatilities on Pharvaris and Easton Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Easton Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Easton Pharmaceutica.

Diversification Opportunities for Pharvaris and Easton Pharmaceutica

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pharvaris and Easton is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Easton Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Easton Pharmaceutica and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Easton Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Easton Pharmaceutica has no effect on the direction of Pharvaris i.e., Pharvaris and Easton Pharmaceutica go up and down completely randomly.

Pair Corralation between Pharvaris and Easton Pharmaceutica

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Easton Pharmaceutica. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 20.71 times less risky than Easton Pharmaceutica. The stock trades about 0.0 of its potential returns per unit of risk. The Easton Pharmaceutica is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Easton Pharmaceutica on September 4, 2024 and sell it today you would earn a total of  0.01  from holding Easton Pharmaceutica or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Pharvaris BV  vs.  Easton Pharmaceutica

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
Easton Pharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Easton Pharmaceutica has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Easton Pharmaceutica is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pharvaris and Easton Pharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Easton Pharmaceutica

The main advantage of trading using opposite Pharvaris and Easton Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Easton Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easton Pharmaceutica will offset losses from the drop in Easton Pharmaceutica's long position.
The idea behind Pharvaris BV and Easton Pharmaceutica pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stocks Directory
Find actively traded stocks across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories